MRNA (NASDAQ:MRNA) reported quarterly earnings results on September 30, 2025 that exceeded analyst expectations. The company reported earnings per share of $-0.51, beating the…
MRNA (NASDAQ:MRNA) reported quarterly earnings results on September 30, 2025 that exceeded analyst expectations.
The company reported earnings per share of $-0.51, beating the consensus estimate of $-2.15 by $1.64 per share. Revenue came in at $0, meeting the estimate of $0.
MRNA's stock moved following the earnings release. The stock currently trades at $0.00 with a market capitalization of $0.
Current market data
NASDAQ · MRNA
$197.28
Down: -$1.60 · -0.80%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
